111 related articles for article (PubMed ID: 1611016)
41. Endothelin-induced contraction of the portal vein in cirrhosis.
Petrowsky H; Schmandra T; Lorey T; Hanisch E; Herrmann G
Eur Surg Res; 1999; 31(3):289-96. PubMed ID: 10352358
[TBL] [Abstract][Full Text] [Related]
42. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
43. Metabolic and hemodynamic responses of bivascularly perfused rat liver to nerve stimulation, noradrenaline, acetylcholine and glucagon in thioacetamide-induced micronodular cirrhosis.
Zimmermann T; Gardemann A; Machnik G; Dargel R; Jungermann K
Hepatology; 1992 Mar; 15(3):464-70. PubMed ID: 1544628
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
45. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats.
Yang YY; Lee TY; Huang YT; Chan CC; Yeh YC; Lee FY; Lee SD; Lin HC
Liver Int; 2012 Jan; 32(1):48-57. PubMed ID: 22098317
[TBL] [Abstract][Full Text] [Related]
46. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver.
Wang HG; Shibamoto T; Miyahara T
Am J Physiol; 1997 Nov; 273(5):G1036-43. PubMed ID: 9374700
[TBL] [Abstract][Full Text] [Related]
47. Pancreatic endocrine function in cirrhotic rats.
Nakamura T; Otsuki M; Tani S; Okabayashi Y; Fujii M; Oka T; Fujisawa T; Baba S
Metabolism; 1988 Sep; 37(9):892-9. PubMed ID: 3047524
[TBL] [Abstract][Full Text] [Related]
48. Norepinephrine-induced cholestasis in the isolated perfused rat liver is secondary to its hemodynamic effects.
Lenzen R; Funk A; Kolb-Bachofen V; Strohmeyer G
Hepatology; 1990 Aug; 12(2):314-21. PubMed ID: 2391070
[TBL] [Abstract][Full Text] [Related]
49. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
[TBL] [Abstract][Full Text] [Related]
50. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis.
Jiao LR; Seifalian AM; Habib N; Davidson BR
Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637
[TBL] [Abstract][Full Text] [Related]
51. Norepinephrine: a potential modulator of the hepatic transport of taurocholate. a study in the isolated perfused rat liver.
Ballet F; Chretien Y; Rey C; Poupon R
J Pharmacol Exp Ther; 1987 Jan; 240(1):303-7. PubMed ID: 3806392
[TBL] [Abstract][Full Text] [Related]
52. 5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes.
Graupera M; García-Pagán JC; Titos E; Claria J; Massaguer A; Bosch J; Rodés J
Gastroenterology; 2002 Feb; 122(2):387-93. PubMed ID: 11832453
[TBL] [Abstract][Full Text] [Related]
53. Hepatic hemodynamics and functions in extrahepatic portal obstruction in the rat with liver cirrhosis.
Omokawa S; Saitoh H; Arai Y; Itoh M; Furuya T; Asanuma Y; Koyama K
Hepatogastroenterology; 1991 Feb; 38(1):56-9. PubMed ID: 2026390
[TBL] [Abstract][Full Text] [Related]
54. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
55. Portal vein clamping alone confers protection against hepatic ischemia-reperfusion injury via preserving hepatocyte function in cirrhotic rats.
Hu JJ; Li CH; Wang HD; Xu WL; Zhang AQ; Dong JH
J Surg Res; 2015 Mar; 194(1):139-46. PubMed ID: 25481529
[TBL] [Abstract][Full Text] [Related]
56. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
57. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
58. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
59. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
[TBL] [Abstract][Full Text] [Related]
60. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
